The Wall Street Journal @WSJ

Novo Nordisk​’s ​new CEO, Maziar Mike Doustdar, will ​contend with a challenging landscape in the U.S., where ​the company faces its biggest competitive threats https://t.co/0cqKRW8yeb

www.wsj.com

Can Novo Nordisk’s New CEO Stop Rivals From Taking Over the Anti-Obesity Market?

The company’s first non-Danish leader will face a challenging landscape among competitors